TGA Approval

BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial (453648)

ARTG ID

453648

ARTG Name

BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial

Sponsor

Accelagen Pty Ltd

ARTG Date

June 11, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ACCELAGEN PTY LTD

https://medical-cdn.nocode.com/drug_tga/2cde47e749e26c9d495480f584743c71.pdf

https://medical-cdn.nocode.com/drug_tga/6f2261e832d9c9c4762ab03056afea37.pdf

Ingredient Name

ublituximab

Empowering clinical research with data-driven insights and AI-powered tools.

BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial (453648) - TGA 批准文号 | MedPath